Private equity firm Warburg Pincus LLC is to sell 2.77 million shares of portfolio company China Biologic Products in a partial exit, according to a company announcement.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!Register Now
Already have an account or paid subscription?